CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced the posting of the management presentation recording from the 2014 Annual Shareholders Meeting held on July 30th, 2014. The recording is available on the investor relations page of InVivo’s website - http://www.invivotherapeutics.com/investor-relations/
Mark Perrin, Chief Executive Officer, said, “I am very pleased with the turnout at this year’s annual shareholders meeting. It was a great opportunity for me and our CSO, Tom Ulich, to tell the updated InVivo story directly to our shareholders. I’m grateful for the support and feedback I received, and I look forward to continued interactions with our investors and the investment community going forward.”
About InVivo Therapeutics
InVivo Therapeutics Holdings Corp. is a pioneering biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, ScD., Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, MD, who is affiliated with Massachusetts General Hospital. In 2011 the company earned the David S. Apple Award from the American Spinal Injury Association for its outstanding contribution to spinal cord injury medicine. The publicly-traded company is headquartered in Cambridge, MA. For more details, visit, www.invivotherapeutics.com.
